XML 54 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
Going Concern, Significant Risks and Uncertainties - Schedule of company's net sales (Details) - Net Sales - Revenue from Rights Concentration Risk - Revenue channel [Member]
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
VA/DoD [Member]    
Schedule of company's net sales [Line Items]    
Revenue, percentage 60.10% 60.80%
TAC-STIM [Member]    
Schedule of company's net sales [Line Items]    
Revenue, percentage 10.90% 1.50%
National Health Service [Member]    
Schedule of company's net sales [Line Items]    
Revenue, percentage 8.80% 15.10%